| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
| filingDate |
2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-201000265-A1 |
| titleOfInvention |
MCP-1 MUTANTS ANTAGONISTS OF GLYCOSAMINO GLICAN AND METHODS OF THEIR APPLICATION |
| abstract |
New mutants of human monocytic chemoattractant protein 1 (MCP-1) with increased affinity for glycosaminoglycan binding (GAG) and eliminated or reduced GPCR activity compared to wild-type MCP-1 protein and their use for therapeutic treatment of inflammatory diseases. |
| priorityDate |
2007-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |